WY Stat § 35-7-1059 (2021)
2021 Wyoming Statutes|Title 35 - Public Health and Safety|Chapter 7 - Food and Drugs|Article 10 - Controlled Substances|Section 35-7-1059 - Unlawful Clandestine Laboratory Operations; Methamphetamine Precursors; Presumptively Illegal Amount; Methamphetamine Precursor Sales Limitations; Registration Requirements; Reports; Penalties.

35-7-1059. Unlawful clandestine laboratory operations; methamphetamine precursors; presumptively illegal amount; methamphetamine precursor sales limitations; registration requirements; reports; penalties.| (a) It is unlawful for any person to knowingly or intentionally:  (i) Possess a List I or II controlled substance precursor with the intent to engage in a clandestine laboratory operation;  (ii) Possess laboratory equipment or supplies with the intent to engage in a clandestine laboratory operation;  (iii) Sell, distribute or otherwise supply a List I or II controlled substance precursor, laboratory equipment or laboratory supplies knowing it will be used for a clandestine laboratory operation;  (iv) Conspire with or aid another to engage in a clandestine laboratory operation.  (b) A person who violates subsection (a) of this section is guilty of a felony punishable by imprisonment for not more than twenty (20) years, a fine of not more than twenty-five thousand dollars ($25,000.00), or both.  (c) A person who violates subsection (a) of this section is guilty of a felony punishable by imprisonment for not more than twenty-five (25) years, a fine of not more than fifty thousand dollars ($50,000.00), or both if the judge or jury also finds any one (1) of the following conditions occurred in conjunction with that violation:  (i) Illegal possession, transportation or disposal of hazardous or dangerous material or while transporting or causing to be transported materials in furtherance of a clandestine laboratory operation, there was created a substantial risk to human health or safety or a danger to the environment;  (ii) The intended laboratory operation was to take place or did take place within five hundred (500) feet of a residence, business, church or school; or  (iii) Any phase of the clandestine laboratory operation was conducted in the presence of a person less than eighteen (18) years of age.  (d) A person who violates subsection (a) of this section is guilty of a felony punishable by imprisonment for not more than forty (40) years, a fine of not more than one hundred thousand dollars ($100,000.00), or both if the judge or jury also finds any one (1) of the following conditions occurred in conjunction with that violation:  (i) Use of a firearm;  (ii) Use of a booby trap.  (e) Except as provided in this subsection, no person shall possess a drug product containing more than fifteen (15) grams of ephedrine, pseudoephedrine or phenylpropanolamine, or their salts, isomers or salts of isomers. This subsection shall not apply to the following persons who are lawfully possessing drug products in the course of legitimate business:  (i) A retail distributor or wholesaler of drug products registered with the board;  (ii) A wholesale drug distributor licensed by the board;  (iii) A drug manufacturer licensed by the board;  (iv) A pharmacist licensed by the board;  (v) A licensed health care professional possessing the drug products in the course of practicing his profession;  (vi) A person in possession of more than fifteen (15) grams of methamphetamine precursor drugs in the person's home or residence under circumstances consistent with typical medicinal or household use as indicated by, but not limited to, storage location and possession of products in a variety of strengths, brands, types, purposes and expiration dates.  (f) A person who knowingly or intentionally violates subsection (e) of this section is guilty of a felony punishable by imprisonment for not more than fifteen (15) years, a fine of twenty-five thousand dollars ($25,000.00), or both.  (g) The retail sale of methamphetamine precursor drugs shall be limited as follows:  (i) No person shall obtain more than a total of three and six-tenths (3.6) grams per calendar day, regardless of the number of transactions, of one (1) or more methamphetamine precursor drugs, calculated in terms of the active equivalent of ephedrine base, pseudoephedrine base or phenylpropanolamine base;  (ii) Sales in blister packs, each blister containing not more than two (2) dosage units or, when the use of blister packs is not technically feasible, sales in unit dose packets or pouches;  (iii) No person shall obtain more than nine (9) grams of ephedrine base, pseudoephedrine base or phenylpropanolamine base, of which no more than seven and one-half (7.5) grams can be imported by private or commercial carrier or the United States postal service, during any thirty (30) day period.  (h) No person shall sell in a single retail transaction more than two (2) packages of a product containing methamphetamine precursor drugs. The seller shall maintain a written or electronic list of such sales in a logbook that identifies the products by name, the quantity sold, the names and addresses of purchasers, and the date and time of the sales except that such requirement does not apply to any purchase by an individual of a single sales package if that package contains not more than sixty (60) milligrams of pseudoephedrine. The seller shall maintain each entry in the logbook for not fewer than two (2) years after the date on which the entry is made. The regulated seller who in good faith releases logbook information to federal, state or local law enforcement authorities is immune from civil liability for such release unless the release constitutes gross negligence or intentional, wanton or willful misconduct.  (j) A retail distributor of products containing methamphetamine precursors shall sell them in one (1) of the following ways:  (i) Product packages are displayed behind a store counter, in an area not accessible to customers;  (ii) Product packages are displayed in a locked case so that a customer must ask a store employee for assistance in purchasing the product;  (iii) Product packages are displayed within thirty (30) feet of and in the direct line of sight of a cash register or store counter staffed by a store employee and the store employs a reliable alarm system to prevent the theft of multiple product packages;  (iv) Product packages are displayed in a location that is under constant video surveillance and:  (A) Persons examining or removing packages are within the camera's view;  (B) The video camera records recognizable images at least once every ten (10) seconds;  (C) Surveillance images are preserved for at least one hundred sixty-eight (168) hours and are available to law enforcement authorities immediately upon request;  (D) The retail distributor posts a sign in a prominent manner stating that the area is under constant video surveillance;  (E) The retail distributor reports to local law enforcement any theft or suspected thefts.  (k) A person who intentionally or knowingly violates subsection (g), (h) or (j) of this section is guilty of a misdemeanor punishable by a fine of one hundred dollars ($100.00) for a first offense, five hundred dollars ($500.00) for a second offense within two (2) years and one thousand dollars ($1,000.00) and up to six (6) months imprisonment, or both, for a third offense within three (3) years.  (m) A resident or nonresident retailer, manufacturer or wholesaler who distributes ephedrine, pseudoephedrine or phenylpropanolamine, or their salts, isomers or salts of isomers in Wyoming shall:  (i) Register with the board by submitting an application on a form prescribed by the board and pay a registration fee of twenty-five dollars ($25.00). Where the retailer, manufacturer or wholesaler distributions are conducted at more than one (1) location, each location shall be separately registered. Except as provided in subsection (n) of this section, those facilities registered with the board under W.S. 35-7-1024 on July 1, 2005, shall not be required to register under this section;  (ii) Notify the board of the occurrence of any of the following:  (A) The permanent closing of the retailer, manufacturer or wholesaler outlet;  (B) A change in ownership, name, management or location.  (iii) Be subject to inspection by the board. Inspections shall be conducted during normal business hours and shall be limited to the following:  (A) For retail distribution, inspection of the method of display and sale of any drug products covered by this section;  (B) For manufacturer or wholesaler distribution, inspection of the purchase and sale records of any drug products covered by this section.  (iv) Display the registration issued by the board in a conspicuous location in the place of business;  (v) Repealed By Laws 2011, Ch. 45, § 2.  (n) A registration issued under this section shall be renewed annually, on or before September 30, by submitting a renewal application supplied by the board and paying the renewal fee of twenty-five dollars ($25.00). Renewal applications postmarked after September 30 shall be subject to a late fee of fifty dollars ($50.00) which shall be in addition to the renewal fee.  (o) The board may revoke, suspend or assess an administrative penalty for violations of subsection (m) of this section not to exceed one hundred dollars ($100.00) for a first offense, five hundred dollars ($500.00) for a second offense within two (2) years and one thousand dollars ($1,000.00) for a third offense within three (3) years. Any administrative penalty assessed shall be paid to the board who shall remit the monies to the county treasurer to the credit of the public school fund of the county in which the violation occurred.  (p) For purposes of this section, "methamphetamine precursor drug" means any product that contains ephedrine, pseudoephedrine or phenylpropanolamine or liquid products with ephedrine or pseudoephedrine as the sole active ingredient and may be marketed or distributed lawfully in the United States under the Federal Food, Drug and Cosmetic Act as a nonprescription drug.  Article X